News & Analysis as of

Capital Markets › Capital Raising › Hong Kong Stock Exchange

Conyers

The Surge in Secondary Listings on the Hong Kong Stock Exchange

Conyers on

The Hong Kong Stock Exchange (HKEX) is back challenging for the top of the global listing league tables with secondary listings helping drive the recent surge of activity. In the past, secondary listings on the HKEX have...more

Skadden, Arps, Slate, Meagher & Flom LLP

Report on Hong Kong-Listed Biotech Companies - April 2023

Skadden, Arps, Slate, Meagher & Flom LLP on

点击此处阅读调查报告全文 Our third annual report on Hong Kong-listed biotech companies examines how the sector performed during the challenging conditions for capital markets globally over the past 12 months. Although aggregate listing...more

Skadden, Arps, Slate, Meagher & Flom LLP

Hong Kong’s Exchange Improves Its Allure for Chinese Issuers

Skadden, Arps, Slate, Meagher & Flom LLP on

Despite the impact of COVID-19 and other recent developments in Hong Kong, the city’s role as a center for China-based companies to raise capital became even more important in 2020. The momentum of several trends that began...more

Skadden, Arps, Slate, Meagher & Flom LLP

Skadden's 2019 Insights: New HKEx Rules Spur Bumper Year in Hong Kong Capital Markets, but Lasting Impact Remains Unclear

Skadden, Arps, Slate, Meagher & Flom LLP on

In April 2018, the Hong Kong Stock Exchange’s (HKEx) rule amendments permitting the listing of innovative, high-growth companies with dual-class share structures and pre-revenue biotech companies went into effect. The...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide